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Abstract: Nicotinic acid is shown to be comparable to dihydropyridine in its capacity to facilitate
penetration of an attached antibacterial drug through dermal layers. Antibacterial drugs examined
with nicotinic acid or dihydropyridine carriers were β-lactam antibiotics: methicillin, oxacillin,
benzylpenicillin, penicillin F, penicillin dihydro F, propicillin, carbenicillin, penicillin K, penicillin
X, and ampicillin. An oxymethyl (-O-CH2-) group is inserted as the linker between the antibiotic
and the carrier group. Structure Property Correlations and multivariate methods such as regression
analysis, cluster analysis, principal component analysis, discriminate analysis, self-organizing tree
algorithm, and factor analysis clearly showed that nicotinic acid performs as an effective carrier
drug and is comparable to dihydropyridine. The skin penetration constant Kp was calculated for all
10 antibiotics having either dihydropyridine or nicotinic acid as carrier, and was found to have a
mean of 5.13E-05 cm/hour and 1.83E-05 cm/hour, respectively. The standard deviation for each
group showed the numerical values overlap as did the 90% confidence interval for each group. A
hierarchical tree organization of skin shows the overlapped dermal layers as they exist in normal
skin and for the model utilized in this work. A Deming-Regression analysis also shows the nicotinic
acid and dihydropyridine structures to have similar and correlated water solubility. Plotting Kp of
the dihydropyridine structures as independent variable versus Kp of the nicotinic acid structures
show good correlation (Pearson correlation r = 0.6606) and no significant departure from linearity.
Connected box plots showed the majority of Kp values for each group of modified antibiotics to
exist in a tight cluster. Polar graph of the Log Kow values showed the two groups of modified anti-
biotics to be correlated and numerically adjacent in trend. ChemSketch property calculations and
modeling demonstrates the affects of structural oxygens, nitrogens, carbonyl groups, amide groups,
and aromatic rings that are important in understanding the pervasiveness through dermal layers.
Continuous model analysis by acslXtreme is utilized and demonstrates three models of the disper-
sion of drugs through dermal layers based on diffusivity constant (D), Log Kp from Log Kow and
formula weight, and Kp as a function of time.
PENICILLIN ANTIBIOTICS are bactericidal and interfere with the formation of the
bacterial cell wall. Penicillins diffuse well into the body tissues and fluids. Penicillins are
also referred to as the β-lactam antibiotics, a term which indicates the active amide ring
that nullifies the membrane closing activity of transpeptidase enzyme. Ampicillin, one of
the most widely used of the β-lactam antibiotics, is utilized as a topical drug but limited
by resistant Staphylococcus aureus. Important classes of the β-lactam group are the peni-
cillins, cephalosporins, monobactams, and carbapenems.
Bacteria which are important for skin and soft tissue considerations are the Staphylo-
coccus (S.) aureus, S. pyogenes, S. epidermidis, and Pasteurella. Strains of the genus Pas-
teurella (gram-negative, coccobacilli) are susceptible to penicillin as well as tetracycline.
Staphylococci are gram positive spherical bacteria that are found primarily on the skin or
the mucous membranes for which methicillin or vancomycin are effective treatments. Iso-
lates of Staphylococcus aureus can still be inhibited by penicillin, however resistance to
this antibiotic is a significant problem in health facilities. Staphylococcus are opportunis-
tic pathogens, not significantly invasive unless given the opportunity by skin trauma, lac-
erations, macerations, etc. S. aureus causes localized skin infections. S. epidermidis
resides primarily in the skin and can cause blood infections if an invasive trauma provides
the opportunity. The Staphylococci can adhere to epithelial cells causing problems of mul-
tiplication and spread.
To treat the infection threats described above steps have been taken to improve the de-
livery of antibiotics into skin tissue. Particularly the application of dihydropyridine at-
tached β-lactam antibiotics to improve delivery through biological membranes (1, 2, 3).
Induction of skin blisters have been utilized to understand the process of skin absorption
of antibiotics (4). The penetration of skin by antibiotics has been shown to be inhibited
by other medicinal agents such as hydrocortisone (5). Utilizing tissue cages has shown
useful in determining the extent of antibiotic skin penetration (6). 
The β-lactam antibiotics are highly effective against most bacteria that cause skin and
soft tissue infections (7) and are considered to have good tissue penetration and long du-
ration of activity (7) (with the low molecular weight members being optimal). Previous
studies have shown that electrophoresis and phonophoresis can improve tissue penetration
of penicillin and streptomycin (8, 9). Use of 6-ketocholestanol has been shown to enhance
transdermal delivery of antibiotic (10). 
This work shows that nicotinic acid is an effective carrier vehicle which is comparable
to dihydropyridine for enhancing skin penetration by β-lactam antibiotics. Ten antibiotics
that are currently used in clinical applications were selected for evaluating this mode of
enhanced penetration. Each having an attached dihydropyridine or nicotinic acid molecule
at the carboxyl group of the antibiotic (total of 20). Use of nicotinic acid as a carrier ve-
hicle will benefit the clinical treatment of skin infections. 
Materials and Methods 
Numerical Analysis Methods
Multivariate methods such as regression analysis, cluster analysis, principal component
analysis, discriminate analysis, self-organizing tree algorithm, and factor analysis were
applied to molecular properties of the antibiotic structures having nicotinic acid or dihy-
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dropyridine substituents. Dendrograms were utilized to portray distances obtained from
cluster analysis. Descriptive statistics were applied to demonstrate numerical relationships
of molecular properties for all compounds. 
Software and Algorithms
Molecular properties were calculated by utilizing ChemSketch (Advanced Chemistry De-
velopment, Toronto, Canada M5H 3V9), Molinspiration Cheminformatics (SK-84104
Bratislava, Slovak Republic), and Syracuse Research Corp. (North Syracuse, New York
13212). Values of Log Kow, rate of ester hydrolysis, water solubility, and dermal pene-
tration rate were evaluated by EPISUITE (US Environmental Protection Agency, Wash-
ington, DC USA). Self organizing tree algorithm (SOTA) was accomplished by GEPAS
Bioinformatics (http://gepas.bioinfo.cnio.es/cgi-bin/sotarray). Hierarchical tree organiza-
tion of skin structure was accomplished by Treepad (Freebyte, Interland Copyright ©
1995–2003) and FLOW (Version 4.00.074 IMSI and COREL Corp. Copyright ©
1996–1998). 
Continuous Model System
The acslXtreme software was utilized to evaluate dermal penetration by a continuous
model system and determine skin absorption parameters (Aegis Technologies Group, 631
Discovery Drive, Huntsville, AL 35806). 
Descriptors of Dermal Absorption 
Skin Permeability Coefficient, Kp (cm/hour):
Log Kp = −2.72 + 0.71LogKow − 0.0061(Formula Weight) 
Skin Diffusivity Constant, D (cm2/hour):
Log D = −2.72 − 0.0061(Formula Weight) + Log(L),
where, L = length of stratum corneum (0.004 cm) 
Lag Time, τ (hour):
τ = (L)2/6(D), see L and D above. 
Drug penetration (cm) as function of Time (hours) and Kp (see above):
Penetration depth = Kp(Time) 
Permeation Coefficient of Protein Layer, Kpol 
Kpol = 0.0002976/(Formula Weight)0.7
Permeation Coefficient of Aqueous Layer, Kaq 
Kaq = 4.209/(Formula Weight)0.7
Results and Discussion
The skin is a highly organized, multilayered, and heterogeneous organ. The skin produces
factors that regulate growth, differentiation, and mediators of inflammation and immune
response. The skin is made up of three distinct layers: 1) Epidermis (keratinized surface
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layers), 2) Dermis (fibro-elastic connective tissue), and 3) Hypodermis (loose connective
tissue). The dermis contains blood vessels which serve as an entrance portal to the body
for drugs administered as topical agents. General functions of the skin can be described
as: 1) Protective, 2) Inhibitory of microbial activity, 3) Regulation of temperature, and 4)
Repressing of U.V. light damage. For considerations of skin modeling and skin perme-
ation, it is taken to consist of three compartments: 1) Protein layer of the stratum
corneum, 2) Lipid layer of the stratum corneum, and 3) Aqueous layer below the stratum
corneum (drugs applied topically must permeate the aqueous layer to enter the blood-
stream). These factors of skin constitution and activity are considered here in the com-
parison of antibiotics having either a dihydropyridine or nicotinic acid substituent. The
stratum corneum is the rate-limiting diffusion barrier for most compounds and will be
considered in this study.
Dihydropyridine has been used as a substituent of different classes of drugs to facili-
tate the penetration of membrane tissue such as the blood-brain-barrier. It has been uti-
lized previously to enhance the membrane penetration of β-lactam antibiotics for targeting
the central nervous system (11, 12, 3). The synthesis of the dihydropyridine variants of
these antibiotics is straight forward and would be accomplished in the same manner for
all antibiotic nicotinic acid variants. Briefly, all of the β-lactam antibiotics studied have a
carboxylic acid group which is converted to a potassium salt by mild base. Then
chloromethanechlorosulfate is introduced which produces a chloromethyl ester group (ie.,
-C(O)OCH2Cl). Upon introduction of nicotinic acid or dihydropyridine, the formation of
the final daughter compound having the desired substituent is energetically favored and is
readily obtained (see Figure 1 for example final structures). It has been shown in previ-
ous studies that nicotinic acid functioning as a carrier drug will enhance the penetration
of antineoplastic alkylating nitrogen mustard groups through the blood-brain-barrier (13).
Figure 1 shows a methicillin nicotinic acid and methicillin dihydropyridine products of
the reaction of chloromethanechlorosulfate with a β-lactam antibiotic, followed by the de-
sired substituent. Notice the β-lactam ring is intact and a methoxy (-O-CH2-) linker is in
place between the antibiotic proper and the subtituent (see dotted rectangle). The SMILES
notation (www.daylight.com) for each compound is given. The nicotinic acid and dihy-
dropyridine constitute the “carrier” portion of these antibiotic variants which enhances
their penetration through body membranes. 
Organization of dermal layers comprising the skin is presented in Figure 2 as a hierar-
chical tree organization. The layers which are significant in their influence on drugs ap-
plied topically are shown. On the left is the tree organization with the important layers
designated as nodes of that tree. To the top of the left-hand tree is the initial administered
drug, followed by the epidermis which is in turn comprised by the protein layer, lipid
layer, and aqueous layer in sequence as the drug penetrates the skin in depth. The drug
must pass the aqueous layer prior to reaching the dermis, which has the blood capillaries
which provide passage of the drug to other parts of the body. The hypodermis being a
major layer also. The right-hand tree shows the important layers of the epidermis more
clearly distinct from the underlying dermis and hypodermis. 
Molecular properties for both the nicotinic acid antibiotic variants and the dihydropy-
rildine antibiotic variants are presented in Table I. Note that the antibiotic forms and their
properties are designated by columns and placed in the same vertical columns to facilitate
comparisons of values. The molecular properties considered are as follows from left to
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FIGURE 1. Examples of the molecular structures for each group of antibiotic derivatives of nico-
tinic acid or dihydropyridine utilizing methicillin as the parent compound. SMILES notation is
given for each structure. Note the (-O-CH2-) linker connecting the antibiotic to the carrier group.
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FIGURE 2. Showing the hierarchical tree organization of normal skin, any topically applied drug
will pass through the protein, lipid, and aqueous layers of the epidermis prior to reaching the blood
capillaries of the dermis layer. 
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right in Table I: formula weight, molar refractivity, molar volume, parachor, index of re-
fraction, polarizability, nOnN (number of oxygens and number of nitrogens), nNHnOH
(number of -NH and number of -OH), Log P by Molinspiration (miLog P), and polar sur-
face area by Molinpiration (TPSA). Polar surface area has been shown to be an accurate
indicator of absorption of a drug through the intestinal tract (14). All of the antibiotic vari-
ants shown in Table I (all of dihydropyridine and nicotinic acid forms) have TPSA values
ranging from about 105 A2 to about 142 A2, which indicate levels of intestinal absorption
of 10% to 30%, respectively (14). 
The skin permeability coefficient Kp is an important property and can be utilized to ap-
proximate the distance into the skin a drug will travel as a function of time. The values of
Kp for all antibiotics with nicotinic acid or dihydropyridine as carrier is given in Table II
as calculated by EPISUITE. The average value of Kp for each group are comparable,
being 5.13E-05 cm/hr and 1.83E-05 cm/hr for dihydropyridine and nicotinic acid struc-
tures, respectively. Frequency analysis of the Kp values for the dihydropyridine structures
reveal 90% confidence interval of 1.47E-05 cm/hr to 8.79E-05 cm/hr (outliers will be
>0.0000795 from the median of 2.46E-05 cm/hr), skewness of 1.794, and kurtoses of
2.388. Frequency analysis of the Kp values for the nicotinic acid structures reveal 90%
confidence interval of 5.70E-06 cm/hr to 3.09E-05 cm/hr (an overlap of the same range
for the dihydropyridine structures), having skewness of 2.430, and kurtoses of 6.454 (out-
liers will be >0.0000301 from the median of 1.09E-05 cm/hr). Water solubilities for all
antibiotics of nicotinic acid and dihydropyridine structure is shown in Table II in mg/mL.
Although values vary widely within each group of compounds the numerical values them-
selves are comparable as a group. Note that each group has only a single outlier as a func-
tion of water solubility, that compound being benzylpenicillin for each group. The
Grubb’s Test for detecting outliers is also called the ESD method or extreme studentized
deviate, and indicates that a value is unlikely to come from the same Gaussian population.
Z values are calculated and a high Z value indicates that data is far from the other mem-
bers of the group. Consequently, in terms of the two important properties Kp and water
solubility the nicotinic acid group of structures are clearly similar to the dihydropyridine
structures of antibiotics.
Analysis of molecular properties for these two groups of compounds by self organiz-
ing tree algorithm (SOTA) clearly showed mutual similarities and interrelationships. The
results of SOTA analysis is in the form of cluster output which can also be defined in
terms of proximity and distance associations (ie., single linkage and euclidean distance).
SOTA (15) analysis was applied to seven molecular properties of these two groups in the
following order: formula weight, molar refractivity, molar volume, parachor, index of re-
fraction, polarizability, and number of oxygens and nitrogens. For ten compounds in each
group that gives a total of 140 data points analyzed by SOTA. Parameters of the SOTA
analysis were single linkage and standard euclidean distances. The results consisted of
two clusters having members of both groups interwoven as follows: CLUSTER 1: Nico-
tinic acid structures of methicillin, propicillin, penicilliln K with dihydropyridine struc-
tures of methicillin, oxacillin, propicillin, carbenicillin, penicillin K, and ampicillin.
CLUSTER 2: Nicotinic acid structures of oxacillin, benzylpenicilliln, penicillin F, dihy-
dropenicillin F, carbenicillin, penicillin X, ampicillin with dihydropyridine structures of
benzylpenicilliln, penicillin F, dihydropenicillin F, and penicillin X. Interrelationships and
similarities are clearly shown when members of either the nicotinic acid structures or di-
hydropyridine structures are placed in identical clusters.
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Further evidence of similarity between nicotinic acid and dihydropyridine structures is
elucidated in Figure 3. The skin permeability coefficient Kp values (see Table II) for di-
hydropyridine compounds is plotted (x-axis) versus the corresponding Kp values of their
counter part nicotinic acid structures (y-axis) with the 95% confidence interval (see inset
arrows) in the top plot (see Figure 3). All values fall clearly within the 95% confidence
interval except for penicillin K (see oval indicating this data point). However, a line drawn
from the linear data values near the origin clearly includes the penicillin K data point (see
broken line crossing the oval point value) and leaves out the data point encased in the
inset rectangle (oxacillin). 
A Deming Regression Plot shows linear relationships of data values with the assump-
tions that the values of the independent variable (x-axis) have error. A Deming regression
analysis for the water solubility values (these being important because the drug must cross
the aqueous layer of the epidermis) shown in Table II is presented as the middle plot in
Figure 3. The formula weight of all nicotinic acid and dihydropyridine structures are
plotted as the independent variable (x-axis) versus the water solubility (mg/mL) as the de-
pendent variable (y-axis). Note that all 20 compounds do fall within a linear fashion
according to the least squares line (see Figure 3) and only one compound (the benzyl-
penicillin nicotinic acid, see inset arrow) is radically an outlier from the otherwise linear
body of the data. Therefore, the Deming regression analysis clearly demonstrates the
similarity of all water solubility values for all nicotinic acid and dihydropyridine struc-
tures (high correlation of water solubility to formula weight). 
A polar graph is utilized to demonstrate similarities between data values or groups of
data values. A polar graph is shown (lower left, Figure 3) having Log Kow values for the
dihydropyridine structures indicated by (X) and nicotinic acid structures indicated by tri-
angles (n) . Log Kow values indicate the dispersion of the drug between an organic sol-
vent layer and an aqueous layer while assuming no charge species of the drug exist. Log
Kow is an indicator of the ability of a drug to penetrate lipid by-layers and hence cellular
membranes. Values of Log Kow are an important influence on the pharmacokinetic and
pharmacodynamic aspect of the drug. The polar graph shows the Log Kow values of the
dihydropyridine structures are generally larger that those of the nicotinic acid structures
but corresponding values are clearly in close proximity. 
In the lower right hand corner of Figure 3, a connected box plot for Kp values of
dihydropyridine structures (var 2) are shown compared to Kp values of the nicotinic acid
structures (var 3). In the connected box plot the individual data points are plotted nor-
malized to the average value for that specific group of Kp values. Values for var 2 (dihy-
dropyridine structures) have no outliers and the majority of Kp values are tightly clustered
around the mean value (see Connected Box Plot Figure 3, var 2). Values for var 3 (nico-
tinic acid structures) show one outlier (see var 3 furthest point from origin) which is peni-
cillin K while the remaining members of the group are tightly clustered around the mean
value (see Figure 3 Connected Box Plot, var 3). 
The operation referred to as factor analysis encompasses both component analysis and
common factor analysis. Principal component analysis (PCA) is considered simpler. The
central concept behind PCA is representation and summarization. The action of PCA is
to replace a large set of variables by a smaller set which best summarizes the larger set.
The results of PCA on the Kp values of all dihydropyridine and nicotinic acid structures,
which form PCA 1 (dihydropyridine structures) and PCA 2 (nicotinic acid structures) are
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FIGURE 3. Comparison of important properties of the nicotinic acid group of antibiotics to the di-
hydropyridine group show similarities that support the potential for clinical application of the nico-
tinic acid derivatives. Top Graph: Linear regression plot of Kp values of all compounds show the
majority of derivatives fall together within a 95% confidence interval (indicated by inset arrows)
with only one outlier (inset circle). If a line is formed for linear members only, then again most
compounds are inclusive with only one outlier (see rectangle). Middle Graph: Deming regression
analysis of FW versus water solubility shows clearly the tight linearity of 19 derivatives with only
one outlier (see inset arrow). Polar graph shows consistency and similar trend of Log Kow values
for all 20 compounds (X= dihydropyridine structures, triangles (n)= nicotinic acid structures). Con-
nected box plots show tight clustering of Kp values about the mean value for each group (var2= di-
hydropyridines, var3= nicotinic acids).
seen in Figure 4. A PCA 1 versus PCA 2 plot indicates that 80% of all 20 compounds are
similar and fall within a tight cluster at about the origin of the graph (see inset oval). This
cluster includes the nicotinic acid and dihydropyridine structures of methicillin, ben-
zylpenicillin, penicillin F, dihydropenicillin F, propicillin, carbenicillin, penicillin X, and
ampicillin. The outliers are oxacillin (see inset arrow) and penicillin K (see inset rectan-
gle). Therefore, PCA shows that 80% of all 20 structures are similar.
Cluster analysis (CA) is a multivariate method that acts to organize data about variables
in which homogeneous groups or clusters are formed. The clusters which are formed
should have high internal homogeneity (members similar to each other) and highly exter-
nal heterogeneity (members dissimilar to each other). CA can be applied to a wide variety
of input data. The primary result of CA is the dendogram or tree diagram. In Figure 4 is
seen a dendogram of CA on Kp values for all 20 agents. Note that in each case of the
compound name found in the inset key it represents both the nicotinic acid and dihy-
dropyridine structures (i.e., for 1) Methicillin, it means both the nicotinic acid and dihy-
dropyridine form of methicillin). Using single linkage and standard euclidean the
following clusters are formed (see dendogram of Figure 4): Cluster 1 and 3 (methicillin
and benzylpenicillin); Cluster 4 (penicillin F); Cluster 7, 10, and 9 (carbenicillin, ampi-
cillin, and penicillin K); Cluster 5 and 6 (dihydropenicillin F and propicillin); Cluster 2
(oxacillin); Cluster 8 (penicillin K). Therefore, CA indicates that 70% of all 20 structures
will have similarities with other members of this group.
Factor analysis is utilized to study patterns of relationships among many dependent
variables with the actual goal of discerning characteristics of the independent variables
that affect them (the independent variables are not measured directly). Figure 5 shows the
plot of FA 1 versus FA 2 after factor analysis of Kp values for all nicotinic acid and di-
hydropyridine structures. Parameters of factor analysis were maximum likelihood and Jo-
ereskog’s Formula. Note that the majority (80%) of all 20 antibiotic structures examined
here fall within an individual clustering and close proximity (thus indicating similarity).
Similar compounds that fall within a super cluster include methicillin, benzylpenicillin,
penicillin F, dihydropenicillin F, propicillin, carbenicillin, penicillin X, and ampicillin
(this includes both the nicotinic acid and dihydropyridine structures of these antibiotics).
Outliers not demonstrating similarity with the super cluster are oxacillin (see inset rec-
tangle) and penicillin K (see inset arrow). Therefore it is found that factor analysis also
shows that 80% of both forms of the ten types of antibiotics are similar.
Discriminant analysis (DA) is utilized to determine which variables can be shown to
discriminate between two or more occurring groups. Computationally, DA is very similar
to analysis of variance. DA can be used to determine which variables (descriptors) can
best predict the differing attributes of a particular group. This may also be stated as an
analysis to assess the relative importance of the independent variables in classifying the
dependent variable and to infer meaning of any dimensions that distinguish groups. To ac-
complish DA on the antibiotic structures that are the focus of this study, three molecular
properties of the compounds were selected (formula weight, molar refractivity, and molar
volume) and their numerical values for the dihydropyridine structures placed in Group 1
with those for the nicotinic acid structures placed into Group 2. Discriminant analysis of
Group 1 versus Group 2 produces output referred to as DA 1 and DA 2, respectively. The
plot of DA 1 versus DA 2 is presented in Figure 5 in which both the DA 1 score (x-axis)
and DA 2 score (y-axis) can differentiate three super clusters of these compounds. The
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FIGURE 4. Principal component analysis of Kp values show tight clustering of 80% of all 20 com-
pounds about the origin (see inset oval). Cluster analysis by single linkage and standard euclidean
shows clusters of similar compounds: Cluster 1 and 3 (methicillin and benzylpenicillin); Cluster 4
(penicillin F); Cluster 7, 10, 9 (carbenicillin, ampicillin, and penicillin X); Cluster 5 and 6 (dihy-
dropenicillin F and propicillin); Cluster 2 (oxacillin); Cluster 8 (penicillin K).
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FIGURE 5. Factor analysis shows the strong similarities of nicotinic acid structures with dihy-
dropyridine structures. 80% of all 20 compounds are included within the super cluster about the ori-
gin (see inset oval). Discriminant analysis shows that three properties (formula weight, molar
refractivity, and molar volume) may be used to show similarities and distinctions of dihydropyri-
dine and nicotinic acid derivatives of antibiotics. Distinctions obtained by DA 1 are analogous to
those obtained from DA 2 (both utilizing formula weight, molar refractivity, and molar volume).
super cluster encased within the inset circle includes oxacillin, penicillin K, and propi-
cillin (i.e., these three compounds are similar). Super cluster encased within the inset
square encompasses ampicillin and benzylpenicillin (i.e., these two compounds are simi-
lar). The super cluster encased within the inset oval contains the compounds methicillin,
penicillin F, dihydropenicillin F, penicillin X, and carbenicillin (i.e., these five compounds
are similar). Remember that each data point in the DA graph designates the effects from
both the dihydropyridine and the nicotinic acid forms of the same compound. Therefore,
it is shown that DA will incorporate all 20 compounds studied here within three super
clusters that have distinction from each other. However, members within each group are
thereby similar to each other.  
AcslXtreme is program software which generates continuous numerical results from
system models that incorporate mathematical algorithms designed within a continuous
non-discrete framework. The operator designs a model with mathematical functions that
can represent a real world paradigm. The output of such a model is a continuous numer-
ical representation of the functions comprising the model. Three such models are pre-
sented in Figure 6, each representing some aspect of the application of the antibiotics
studied in this work as topical agents. The first model represents the penetration of a drug
in centimeters as a function of its Kp (skin permeability coefficient) and time in hours.
The output is a 2-dimensional plot of hours (independent variable) versus distance (de-
pendent variable) having equation of line as: y = (2.597E-04cm/hour)x − (2.60E-4cm),
where slope = 2.597E-04cm/hour. The second model variance of Kp as a function of Log
Kow and formula weight (see Materials and Methods). The output of such a model is lin-
ear having formula weight as the independent variable and Log Kow as the dependent
variable. The equation of the line is: y = (−0.7071 amu−1) x − 2.036l, where the slope =
−0.7071 amu−1. The third model represents the evaluation of diffusivity constant D as a
function of formula weight of the drug and depth of stratum corneum (taken here to be
0.004 cm of normal skin). The output is a 2-dimensional plot having formula weight as
the independent variable and values of Log D as the dependent variable. The equation of
the line that formed is (x axis in hour, y axis in cm2/hour): y = (−0.00607 cm2/hour2) x −
5.112 cm2/hour, where slope = −0.00607 cm2/hour2. These equations and the output of
continuous modeling can be utilized to predict important parameters of the topical appli-
cation of drugs. These models present the continuous mathematical expression of the pa-
rameters, however discrete values may be calculated from the equations for each of
diffusivity constant D, Log D, Kaq, and Kpol from values of formula weight and stratum
corneum depth in centimeters. 
The “lag time” of a drug is time required for a topically applied drug to reach the state
in which permeation can be described by Kp, Kpol, Fick’s Law, and other functions of the
drugs activity. Lag time is a function of skin diffusivity constant D, and length of stratum
corneum (see Materials and Methods). Other important parameters for drug dispersion in
skin are the Permeation Coefficient of Protein Layer, Kpol; and Permeation Coefficient of
Aqueous Layer, Kaq. These relationships describe the movement of a drug through the
protein layer and aqueous layer of the epidermis (see Figure 2). Numerical values of both
are a function of formula weight of the drug. Therefore, as formula weight increases the
value of Kpol decreases, as does the value of Kaq. The relationship with formula weight
can be expressed as an equation of a line for Kpol as follows: y = (−3.175E-08)x +
1.455E-05, r = −0.9701and r2 = 0.9412. Similarly, the line formed for Kaq becomes:
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FIGURE 6. Continuous system analysis by acslExtreme can be utilized to obtain these three mod-
els of drug penetration, variance of Kp, and variance of Log D values as a function of time, Kp, Log
Kow, formula weight, and depth of stratum corneum.
y = (−4.495E-04)x + 0.2060, r = −0.9699 and r2 = 0.9407. Therefore, as these β-lactam
antibiotics are converted to their respective nicotinic acid of dihydropyridine derivatives,
the formula weight increases but the values of Kpol and Kaq decrease (i.e., movement of
drug decreases). 
In summation, it is shown that normal skin can be represented by a hierarchical tree di-
agram showing epidermis, dermis, and hypodermis. The carrier groups nicotinic acid and
dihydropyridine are attached to the β-lactam antibiotic by a (-O-CH2-) linker and affect
Log P, water solubility, and other properties of these antibiotics. The Kp values for the
nicotinic acid derivatives of antibiotics are competitive with those of the currently utilized
dihydropyridine derivatives. The nicotinic acid derivatives can by synthesized in the same
manner as the dihydropyridine derivatives, thus posing no obstacle for their manufacture
and testing. Analysis of molecular properties by cluster analysis, principal component
analysis, factor analysis, and discriminant analysis shows clearly that the antibiotic deriv-
atives which have a nicotinic acid or dihydropyridine carrier group attached are similar to
each other. Properties, such as formula weight, molar volume, molar refractivity, water
solubility, for nicotinic acid derivatives are similar and overlap numerically (by standard
deviation) with those of the dihydropyridine derivatives. Therefore, the nicotinic acid de-
rivatives of β-lactam antibiotics are comparable and analogous to the current clinically ap-
plied dihydropyridine derivatives and have a high probability of effective and beneficial
usage in similar clinical applications.
This work was funded by the Medicinal Chemistry Laboratory, Chemistry Department of the Uni-
versity of Nebraska, Omaha USA. 
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